Story perspectives
Study Reveals Ketamine Infusions Offer No Extra Benefits
10/23/2025
36 5
1 of 1
Story summary
- A study published in JAMA Psychiatry found repeated ketamine infusions do not add benefits over standard inpatient care for major depression.
- The trial involved 65 participants and compared ketamine to midazolam, with no significant differences in depression, cognition, or quality of life.
- Researchers noted many participants correctly guessed their treatment, which may have inflated perceived effects, underscoring cautious use of this treatment in Ireland.
